All interested applicants are invited to participate in this event. The objectives of the meeting are as follows:
- Presentation of the call modalities and objectives followed by Q&A session with participants
- Presentation of various perspectives of the remaining challenges that the present call will target (for example in relation to:use of registries, innovation in methodology space, PCOMS, pharmacogenetic biomarkers and pharmacokinetics development, the vision of regulators on future of RD clinical trials, model for innovating therapy in ultra RDs, ethical guidance)
- Open session for participants to discussthe gaps that they would like to tackle and initiate partnerships among interested parties.
The registration to the meeting is mandatory and will close on the 18 of January 2021.
Please register using this link
The detailed agenda of the meeting can be found HERE
If you have any questions or need help please contact us at: innovation.callsec@ejprarediseases.org